Posts tagged sickle cell disease for pharmacists
The tl;dr Pharmacy Journal Club: Voxelotor in Sickle Cell Disease (HOPE Trial)

It’s journal club time! If you've been paying attention to the news this week, you probably saw that Pfizer is voluntarily withdrawing Oxbryta (voxelotor) from the market due to safety concerns. This is an inherent (and unfortunate) risk for drugs approved under the FDA's accelerated approval pathway. Even though the drug itself bit the dust, this journal club still holds up!

Read More
The Pharmacist's Guide to Sickle Cell Disease

For most pharmacists, encounters with sickle cell disease are few and far between. However, if you work in a city (particularly if it's an international hub such as DC or New York), you will encounter sickle cell somewhat regularly.

Read More